Enovis Corporation (ENOV) Financials

ENOV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 3.8 billion 2.4 billion
Dec. 31, 2025 3.8 billion 2.3 billion
Sept. 30, 2025 4.4 billion 2.4 billion
June 30, 2025 5.0 billion 2.4 billion

ENOV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -28.9 million ?
Dec. 31, 2025 32.3 million 8.9 million
Sept. 30, 2025 29.1 million 8.7 million
June 30, 2025 3.4 million 8.7 million

ENOV Net Income

No data available :(

ENOV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 33.1 million 1.3 billion 59.3 million
Dec. 31, 2025 36.4 million 1.3 billion 58.0 million
Sept. 30, 2025 33.6 million 1.3 billion 57.7 million
June 30, 2025 44.1 million 1.4 billion 71.2 million

ENOV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 56.8 million
Dec. 31, 2025 56.8 million
Sept. 30, 2025 56.8 million
June 30, 2025 56.8 million

ENOV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 52.8 million 31.5 million 271.8 million -
Dec. 31, 2025 56.3 million 31.4 million 270.4 million -
Sept. 30, 2025 53.5 million 29.7 million 247.9 million -
June 30, 2025 44.4 million 30.7 million 267.1 million -

ENOV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 589.2 million 265.6 million
Dec. 31, 2025 575.8 million 226.3 million
Sept. 30, 2025 548.9 million 262.2 million
June 30, 2025 564.5 million 229.8 million

ENOV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ENOV

Price: $20.98

52 week price:
20.82
36.82

Payout Ratio Range:
-1.95%
371384.53%

Earnings Per Share: -19.89 USD

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 1.2 billion

Links: